First Trust Advisors’s Amneal Pharmaceuticals AMRX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.28M | Buy |
652,737
+252,443
| +63% | +$2.04M | ﹤0.01% | 1333 |
|
2025
Q1 | $3.35M | Sell |
400,294
-272,109
| -40% | -$2.28M | ﹤0.01% | 1528 |
|
2024
Q4 | $5.33M | Buy |
672,403
+59,601
| +10% | +$472K | ﹤0.01% | 1326 |
|
2024
Q3 | $5.1M | Sell |
612,802
-16,442
| -3% | -$137K | ﹤0.01% | 1332 |
|
2024
Q2 | $4M | Buy |
+629,244
| New | +$4M | ﹤0.01% | 1378 |
|
2020
Q3 | – | Sell |
-221,535
| Closed | -$1.06M | – | 2308 |
|
2020
Q2 | $1.06M | Buy |
221,535
+16,050
| +8% | +$76.4K | ﹤0.01% | 1715 |
|
2020
Q1 | $715K | Sell |
205,485
-39,169
| -16% | -$136K | ﹤0.01% | 1783 |
|
2019
Q4 | $1.18M | Sell |
244,654
-45,679
| -16% | -$220K | ﹤0.01% | 1817 |
|
2019
Q3 | $842K | Buy |
+290,333
| New | +$842K | ﹤0.01% | 1934 |
|
2019
Q1 | – | Sell |
-50,868
| Closed | -$688K | – | 2406 |
|
2018
Q4 | $688K | Buy |
+50,868
| New | +$688K | ﹤0.01% | 2002 |
|